The Novel Anti-Thrombotic Drug with No-Bleeding Excess

Mark IM Noble, Isobel Ford, Gary Cameron and Angela Drake-Holland
Additional contact information
Gary Cameron: Department of Medicine and Therapeutics, University of Aberdeen, Scotland
Angela Drake-Holland: School of Pharmacy, Robert Gordon University, Scotland

Journal of Cardiology & Cardiovascular Therapy, 2017, vol. 6, issue 2, 106-111

Abstract: All anti-thrombotic drugs presently available cause increased bleeding, a most undesirable effect. Our aim was to test a novel anti-thrombotic drug [Th001] which, theoretically should not suffer from this disadvantage..

Keywords: cardiology journal; scholarly articles on cardiology; cardiology citation report; cardiology citations; cardiology medical journals; free cardiology medical journals; cardiology journals; Cardiovascular Therapy; juniper publishers; juniper publishers open access journals (search for similar items in EconPapers)
Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/jocct/pdf/JOCCT.MS.ID.555684.pdf (application/pdf)
https://juniperpublishers.com/jocct/JOCCT.MS.ID.555684.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:ojocct:v:6:y:2017:i:2:p:106-111

DOI: 10.19080/JOCCT.2017.06.555684

Access Statistics for this article

Journal of Cardiology & Cardiovascular Therapy is currently edited by Sophia Mathis

More articles in Journal of Cardiology & Cardiovascular Therapy from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().